153 related articles for article (PubMed ID: 35422521)
1. Sustained BP reduction with renal denervation.
Lim GB
Nat Rev Cardiol; 2022 Jun; 19(6):352. PubMed ID: 35422521
[No Abstract] [Full Text] [Related]
2. Long-term efficacy and safety of renal denervation: an update from registries and randomised trials.
Dimitriadis K; Schmieder RE; Iliakis P; Nickel L; Tsioufis K; Weil J
Blood Press; 2023 Dec; 32(1):2266664. PubMed ID: 37804153
[TBL] [Abstract][Full Text] [Related]
3. The Ongoing Odyssey of Renal Denervation.
Vinayak M; Olin JW; Stone GW
J Am Coll Cardiol; 2023 Nov; 82(19):1824-1827. PubMed ID: 37914511
[No Abstract] [Full Text] [Related]
4. 6- and 12-Month Follow-Up From a Randomized Clinical Trial of Ultrasound vs Radiofrequency Renal Denervation (RADIOSOUND-HTN).
Fengler K; Rommel KP; Kriese W; Blazek S; Besler C; von Roeder M; Desch S; Thiele H; Lurz P
JACC Cardiovasc Interv; 2023 Feb; 16(3):367-369. PubMed ID: 36792266
[No Abstract] [Full Text] [Related]
5. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.
Kjeldsen SE; Os I; Mahfoud F
EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159
[No Abstract] [Full Text] [Related]
6. The randomised Oslo study of renal denervation
Bergland OU; Søraas CL; Larstorp ACK; Halvorsen LV; Hjørnholm U; Hoffman P; Høieggen A; Fadl Elmula FEM
Blood Press; 2021 Feb; 30(1):41-50. PubMed ID: 33030064
[TBL] [Abstract][Full Text] [Related]
7. Renal denervation: a plea for wisdom.
Lantelme P; Courand PY; Pathak A
Arch Cardiovasc Dis; 2013 Mar; 106(3):121-3. PubMed ID: 23582673
[No Abstract] [Full Text] [Related]
8. Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study.
Rosa J; Widimský P; Toušek P; Petrák O; Čurila K; Waldauf P; Bednář F; Zelinka T; Holaj R; Štrauch B; Šomlóová Z; Táborský M; Václavík J; Kociánová E; Branny M; Nykl I; Jiravský O; Widimský J
Hypertension; 2015 Feb; 65(2):407-13. PubMed ID: 25421981
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy and safety of renal denervation: another brick for building a hybrid therapy for hypertension?
Volpe M; Gallo G
EuroIntervention; 2022 Oct; 18(8):e614-e616. PubMed ID: 36205732
[No Abstract] [Full Text] [Related]
10. Editorial commentary: Renal denervation for hypertension: A new meta-analysis promotes further discussion.
Mujadzic H; Mehta ND; Battle SJ; DiPette DJ
Trends Cardiovasc Med; 2023 Nov; 33(8):499-501. PubMed ID: 35777595
[No Abstract] [Full Text] [Related]
11. Renal sympathetic denervation in a previously stented renal artery.
Berra E; Rabbia F; Rossato D; Covella M; Totaro S; Chiara F; Di Monaco S; Veglio F
J Clin Hypertens (Greenwich); 2014 Mar; 16(3):238-9. PubMed ID: 24387740
[No Abstract] [Full Text] [Related]
12. Renal denervation in hypertension: simplicity, or complexity?
Lantelme P; Courand PY; Bricca G
Arch Cardiovasc Dis; 2014; 107(8-9):421-3. PubMed ID: 25128935
[No Abstract] [Full Text] [Related]
13. Can renal denervation replace medications for patients with hypertension?
Sarathy H; Salman LA
Lancet; 2022 Apr; 399(10333):1363-1365. PubMed ID: 35390319
[No Abstract] [Full Text] [Related]
14. Resistant hypertension: Renal denervation or pharmacovigilance? Insights from a renal denervation screening program.
Ojrzanowski M; Kasprzak JD; Peruga JZ; Kurpesa M; Jankowski Ł; Sahni S; Plewka M
Adv Clin Exp Med; 2019 Nov; 28(11):1525-1530. PubMed ID: 31693316
[TBL] [Abstract][Full Text] [Related]
15. Now That Renal Denervation Works, How Do We Proceed?
Papademetriou V; Stavropoulos K; Doumas M; Tsioufis K
Circ Res; 2019 Mar; 124(5):693-695. PubMed ID: 30817252
[No Abstract] [Full Text] [Related]
16. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
[TBL] [Abstract][Full Text] [Related]
17. Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.
Esler MD; Böhm M; Sievert H; Rump CL; Schmieder RE; Krum H; Mahfoud F; Schlaich MP
Eur Heart J; 2014 Jul; 35(26):1752-9. PubMed ID: 24898552
[TBL] [Abstract][Full Text] [Related]
18. Renal sympathetic denervation in resistant arterial hypertension: long term and updated results.
Peregrin JH; Novotný J; Rohál T; Šochman J
Physiol Res; 2019 Mar; 68(1):129-133. PubMed ID: 30848155
[TBL] [Abstract][Full Text] [Related]
19. [Renal denervation in patients with resistant hypertension: is it still possible to resuscitate?].
Táborský M; Schejbalová M
Vnitr Lek; 2014 Dec; 60(12):1081-5. PubMed ID: 25692837
[TBL] [Abstract][Full Text] [Related]
20. Endpoint design for future renal denervation trials - Novel implications for a new definition of treatment response to renal denervation.
Lambert T; Nahler A; Rohla M; Reiter C; Grund M; Kammler J; Blessberger H; Kypta A; Kellermair J; Schwarz S; Starnawski JA; Lichtenauer M; Weiss TW; Huber K; Steinwender C
Int J Cardiol; 2016 Oct; 220():273-8. PubMed ID: 27390940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
